MedPath

Prehabilitation in Adult Patients Following Selective Cardiac Surgery: A Randomized Controlled Trial

Not Applicable
Conditions
Enhanced Recovery
Prehabilitation
Cardiac Surgery
Interventions
Behavioral: Prehabilitation
Behavioral: Standard care
Registration Number
NCT05503004
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

Aim: To determine the impact of an evidence-based comprehensive prehabilitation (EBCPrehab) program on pre- and postoperative capacity, functional capacity and health related quality of life (HRQoL) in patients awaiting elective coronary artery bypass graft surgery (CABG) or valvular surgery. Design: A single-center randomized controlled trail. SUBJECTS: Overall 160 preoperative elective cardiac surgery patients will be randomly assigned to an intervention or control group. Intervention: one-week EBCPrehab intervention, including supervised exercise, mindfulness and nutrition assessment. Control group: usual care. Main measures: At baseline, one day before surgery, three days after surgery and before discharge. The following measurements will be performed: six-minute walk test, ICU delirium, health related quality of life and flow state.

Detailed Description

Enhanced recovery improves the quality of recovery following cardiac surgery, while the evidence of prehabilitation is still limited. We hypothesize that the implementation of a comprehensive prehabilitation program, including physical, mental and nutrition support could optimize the postoperative outcomes during hospital stay.

A randomized controlled study of patients undergoing cardiac surgery with prehabilitation approach, is designed to compare patient outcomes. The samples will be collected from hospital registration and the invention will be conducted before surgery. During the 5-day prehabilitation intervention, patients will receive exercises, mindfulness and nutrition risk assessment. After surgery, the 6-minute walk test, delirium assessment, flow state and health related quality of life will be assessed to explore the effects of prehabilitation on patient outcomes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  • adult patients awaiting selective coronary artery bypass graft surgery (CABG) or valvular surgery
Exclusion Criteria
  • Disability, severe psychiatric disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupPrehabilitationcomprehensive prehabilitation program including supervised exercise., mindfulness and nutrition assessment.
Standard careStandard careStandard care before surgery
Primary Outcome Measures
NameTimeMethod
Preoperative physical functionup to 1 week

6-minute walk test distance in meters

Postoperative physical functionup to 2 weeks

6-minute walk test distance in meters

Secondary Outcome Measures
NameTimeMethod
ICU deliriumUp to 5 days

Assessed by nurses every shift using the Confusion Assessment Method of the Intensive Care Unit -7 (CAM-ICU-7). The CAM-ICU-7 score ranges from 0-7 with 7 being most severe.

Health related quality of lifeup to 4 weeks

Using the The EuroQol 5 Dimension 5 Level (EQ-5D-5L). The EQ-5D-5L defines health conditions based on five dimensions (e.g. mobility, self-care, usual activities, pain/discomfort, and anxiety/depression).

Flow Stateup to 2 weeks

Using the The Flow State Scale for Occupational Tasks (FSSOT). The total score ranges from 14 to 98 points. The high score is considered to indicate the strong flow state in performing a specific task.

Postoperative deliriumUp to 2 weeks

Assessed by nurses every shift using the 4AT Rapid clinical test for delirium. The 4AT is scored from 0-12. A score of 4 or more suggests delirium.

Gut microbiome diversityup to 2 weeks

Stool collection and 16s RNA analysis

Short chain fatty acids (SCFAs)up to 2 weeks

Stool collection and SCFAs quantitative analysis

Trial Locations

Locations (1)

Second Affiliated hospital of Zhejiang university School of medicine

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath